Legacy Private Trust Co. Sells 846 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Legacy Private Trust Co. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,422 shares of the healthcare conglomerate's stock after selling 846 shares during the quarter. Legacy Private Trust Co.'s holdings in UnitedHealth Group were worth $4,935,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Capital & Planning LLC raised its stake in UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after purchasing an additional 79 shares in the last quarter. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in UnitedHealth Group in the fourth quarter valued at about $27,233,000. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Finally, Hanson & Doremus Investment Management grew its position in UnitedHealth Group by 112.9% in the fourth quarter. Hanson & Doremus Investment Management now owns 892 shares of the healthcare conglomerate's stock valued at $451,000 after acquiring an additional 473 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have issued reports on UNH shares. Royal Bank of Canada decreased their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Oppenheimer decreased their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Raymond James cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Finally, Mizuho reduced their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.

Insider Transactions at UnitedHealth Group

In related news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Up 1.0%

UNH traded up $2.91 during trading on Friday, hitting $301.08. The company's stock had a trading volume of 16,265,624 shares, compared to its average volume of 6,788,348. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's fifty day moving average price is $430.87 and its 200-day moving average price is $493.45. The firm has a market capitalization of $273.12 billion, a P/E ratio of 19.42, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.